Aspire Biopharma Holdings ASBP
NASDAQ ASBP
$8.65 -0.07 (-0.80%)
As of: Oct 21, 2026 · 12:31 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Non-Current Debt (2023 - 2025)

Updated

Aspire Biopharma Holdings (ASBP) recorded Non-Current Debt of $500,000 in Q4 2024, up 38.6% from $360,636 a year earlier and unchanged from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Non-Current Debt (2023 - 2025) Analysis & Trends

  • Across earlier years, Non-Current Debt came in at $360,636 in FY2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.50 Mn
Dec 31, 2024 500,000.00
Sep 30, 2024 500,000.00
Dec 31, 2023 360,636.00
API Access

Aspire Biopharma Holdings, Inc. Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ASBP&period=max&api_key=YOUR_API_KEY